SCHEMBL23129147

SCHEMBL23129147

c1ccc2c(c1)ccc1c2[nH]c2ccc3c4ccccc4c4ccccc4c3c21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.61
KDM4E B2RXH2 2/20 0.49
RAB9A P51151 2/20 0.49
SIRT2 Q8IXJ6 1/20 0.49
SIRT1 Q96EB6 1/20 0.49
CDK4 P11802 9/20 0.47
CCND1 P24385 9/20 0.47
HPRT1 P00492 1/20 0.46
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
GABRA2 P47869 1/20 0.46
GABRB2 P47870 1/20 0.46
GABRA4 P48169 1/20 0.46
GABRE P78334 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30914258 0.89 KIF11 (0.66) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL6523866 0.89 KIF11 (0.66) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL30730994 0.89 KIF11 (0.66) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL20311944 0.87 KIF11 (0.55) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL24806935 0.87 KIF11 (0.70) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL17521780 0.85 KIF11 (0.67) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL23129134 0.85 HPRT1 (0.50) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL12240743 0.84 HPRT1 (0.54) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL20427656 0.84 HPRT1 (0.61) KIF11KDM4ERAB9ASIRT2SIRT1
SCHEMBL7080681 0.83 KIF11 (0.53) KIF11KDM4ERAB9ASIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-20210340159-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG CHEM, LTD. (KR) 2021-11-04 US disclosed
EP-3795569-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340159-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME NR4A1, CYP1A1, ARNT KIF11 3843/4885KDM4E 2596/4885RAB9A 2465/4885
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same NR4A1, CYP1A1, ARNT KIF11 3843/4885KDM4E 2596/4885RAB9A 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.